Abstract
Follicular dendritic cell tumor (FDCT) is a rare tumor mainly located in laterocervical lymph nodes. We report one case of mediastinal FDCT associated with a history of bullous skin disease and clinically obvious immunosuppression. This tumor was characterized by heavy mast cell infiltration. Mast cells were in close relationship with tumor cells as demonstrated by ultrastructural examination and their presence are probably related with the strong expression of mast cell chemoattractants as fraktalkine and stromal cell-derived factor-1α by tumor cells. The long follow-up period of more than 17 years allowed to us assess the relatively indolent evolution of this tumor characterized by three slowly growing local recurrences without metastasis.
Similar content being viewed by others
References
Chan JK, Fletcher CD, Nayler SJ, Cooper K (1997) Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer 79:294–313
Coulomb-L’Herminé A, Amara A, Schiff C, Durand-Gasselin I, Foussat A, Delaunay T, Chaouat G, Capron F, Ledee N, Galanaud P, Arenzana-Seisdedos F, Emilie D (1999) Stromal cell-derived factor 1 (SDF-1) and antenatal human B cell lymphopoiesis: expression of SDF-1 by mesothelial cells and biliary ductal plate epithelial cells. Proc Natl Acad Sci U S A 96:8585–8590
Desai SB, Pradhan SA, Chinoy RF (2000) Mediastinal Castleman’s disease complicated by follicular dendritic cell tumour. Indian J Cancer 37:129–132
Fassina A, Marino F, Poletti A, Rea F, Pennelli N, Ninfo V (2001) Follicular dendritic cell tumor of the mediastinum. Ann Diagn Pathol 5:361–367
Foussat A, Coulomb-L’Hermine A, Gosling J, Krzysiek R, Durand-Gasselin I, Schall T, Balian A, Richard Y, Galanaud P, Emilie D (2000) Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur J Immunol 30:87–97
Grogg KL, Lae ME, Kurtin PJ, Macon WR (2004) Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors. Am J Surg Pathol 28:988–998
Husson H, Carideo EG, Cardoso AA, Lugli SM, Neuberg D, Munoz O, de Leval L, Schultze J, Freedman AS (2001) MCP-1 modulates chemotaxis by follicular lymphoma cells. Br J Haematol 115:554–562
Juremalm M, Hjertson M, Olsson N, Harvima I, Nilsson K, Nilsson G (2000) The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin. Eur J Immunol 30:3614–3622
Krober SM, Marx A, Aebert H, Dohmen BM, Kaiserling E (2004) Sarcoma of follicular dendritic cells in the dorsal mediastinum. Hum Pathol 35:259–263
Lin O, Frizzera G (1997) Angiomyoid and follicular dendritic cell proliferative lesions in Castleman’s disease of hyaline-vascular type: a study of 10 cases. Am J Surg Pathol 21:1295–1306
Papadopoulos EJ, Fitzhugh DJ, Tkaczyk C, Gilfillan AM, Sassetti C, Metcalfe DD, Hwang ST (2000) Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin. Eur J Immunol 30:2355–2361
Papadopoulos EJ, Sassetti C, Saeki H, Yamada N, Kawamura T, Fitzhugh DJ, Saraf MA, Schall T, Blauvelt A, Rosen SD, Hwang ST (1999) Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur J Immunol 29:2551–2559
Perez-Ordonez B, Erlandson RA, Rosai J (1996) Follicular dendritic cell tumor: report of 13 additional cases of a distinctive entity. Am J Surg Pathol 20:944–955
Perez-Ordonez B, Rosai J (1998) Follicular dendritic cell tumor: review of the entity. Semin Diagn Pathol 15:144–154
Sakurai S, Hasegawa T, Sakuma Y, Takazawa Y, Motegi A, Nakajima T, Saito K, Fukayama M, Shimoda T (2004) Myxoid epithelioid gastrointestinal stromal tumor (GIST) with mast cell infiltrations: a subtype of GIST with mutations of platelet-derived growth factor receptor alpha gene. Hum Pathol 35:1223–1230
Seishima M, Oda M, Oyama Z, Yoshimura T, Yamazaki F, Aoki T, Nei M, Hashimoto T (2004) Antibody titers to desmogleins 1 and 3 in a patient with paraneoplastic pemphigus associated with follicular dendritic cell sarcoma. Arch Dermatol 140:1500–1503
Sun X, Chang K-C, Abruzzo LV, Lai R, Younes A, Jones D (2003) Epidermal growth factor receptor expression in follicular dendritic cells: a shared feature of follicular dendritic cell sarcoma and Castleman’s disease. Hum Pathol 34:835–840
Tomita Y, Aozasa K, Myoui A, Kuratsu S, Uchida A, Ono K, Matsumoto K (1993) Histologic grading in soft-tissue sarcomas. An analysis of 194 cases including AgNOR count and mast-cell count. Int J Cancer 54:194–199
Yavuz E, Gulluoglu MG, Akbas N, Tuzlali S, Ilhan R, Iplikci A, Akhan SE (2001) The values of intratumoral mast cell count and Ki-67 immunoreactivity index in differential diagnosis of uterine smooth muscle neoplasms. Pathol Int 51:938–941
Acknowledgements
The authors thank Prof. Thierry Molina from the Department of Pathology Hôtel-Dieu AP-HP Paris and Dr Agnès Carlotti from the Department of Pathology Paul Brousse Hospital AP-HP for helpful diagnostic discussions, and Ingrid Durand-Gasselin from Institut Paris-Sud sur les Cytokines Hôpital Antoine Béclère - Clamart for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guettier, C., Validire, P., Emilie, D. et al. Follicular dendritic cell tumor of the mediastinum: expression of fractalkine and SDF-1α as mast cell chemoattractants. Virchows Arch 448, 218–222 (2006). https://doi.org/10.1007/s00428-005-0143-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-005-0143-8